The Wall Street Journal reports that other Southeastern states are beefing up their investments in biotech infrastructure in an effort to catch up to N.C., which is ahead of the curve with the RTP-based N.C. Biotechnology Center. PricewaterhouseCoopers reports the Southeast's market share in biotech and pharmaceuticals has grown dramatically since 1996 - biotech at 12.9 percent from 6.8 percent and pharmaceuticals at 11.8 percent from 2.5 percent.
CED News
« XS Inc. Raises $20 Million | Main | LipoMed Wins $730,000 Contract from CDC »